This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pharma Law USA
October 8 & 9 2024
The Westin Copley PlaceBoston MA

Pharma Law USA

The only pharma event examining antitrust, IP, fraud, compliance & regulation in one place. Your one-stop shop to dissect the latest legal developments affecting the sector.

Avoid costly fines and disputes. Gain practical strategies and connect with in-house counsel, regulators & top legal minds.

Reasons to attend Pharma Law USA 2024:

Explore currently developing legal challenges for the industry. From every angle.

Deep dive into the key legal developments impacting the pharma sector:

Key themes include: 

  • Current challenges in pricing   
  • Patents & IP 
  • Managing transactions
  • Emerging issues
  • Fraud & compliance

Meet the pharma industry in Boston - make connections that matter:

Optimize your compliance strategies by connecting face-to-face with the pharma industry:

  • In-house counsel from across the pharma sector
  • Private practice lawyers specializing in: life sciences, IP, antitrust, regulatory, fraud/white collar crime and compliance 
  • Authorities and regulators 
  • Antitrust economists

Navigate the legal challenges presented by the latest pharma trends:

  • Psychedelics as pharmaceuticals
  • Exploring the risks & opportunities of AI
  • IP in medical devices 
  • Biologics & biosimilars

Connect with the Pharma Industry in Boston:

Join us at the end of Day 1, Tuesday October 8, for a drinks reception to catch up with your peers and make new connections in an informal setting.

Why attend Informa Connect Legal events?

Global Counsel BD & Transactions

Eli Lilly & Co

Of great practical relevance for in-house counsel in the pharmaceutical sector.

Showcase your firm to future clients:

Showcase your knowledge and expertise to a top level audience from across the pharma sector - including a high proportion of in-house counsel.  Get in touch with Thomas Martins to discuss speaking, branding and exhibition opportunities.